BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22510671)

  • 1. Safety of low doses of quetiapine when used for insomnia.
    Coe HV; Hong IS
    Ann Pharmacother; 2012 May; 46(5):718-22. PubMed ID: 22510671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [No quetiapine for sleeping disorders].
    Tak LM; van Berlo-van de Laar IR; Doornbos B
    Ned Tijdschr Geneeskd; 2013; 157(4):A5740. PubMed ID: 23343742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of quetiapine on sleep in nonpsychiatric and psychiatric conditions.
    Wine JN; Sanda C; Caballero J
    Ann Pharmacother; 2009 Apr; 43(4):707-13. PubMed ID: 19299326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quetiapine for insomnia associated with refractory depression exacerbated by phenelzine.
    Sokolski KN; Brown BJ
    Ann Pharmacother; 2006 Mar; 40(3):567-70. PubMed ID: 16478812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quetiapine for insomnia: A review of the literature.
    Anderson SL; Vande Griend JP
    Am J Health Syst Pharm; 2014 Mar; 71(5):394-402. PubMed ID: 24534594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quetiapine for primary insomnia: a double blind, randomized controlled trial.
    Tassniyom K; Paholpak S; Tassniyom S; Kiewyoo J
    J Med Assoc Thai; 2010 Jun; 93(6):729-34. PubMed ID: 20572379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of quetiapine use in psychiatric inpatients: an examination of off-label use.
    Philip NS; Mello K; Carpenter LL; Tyrka AR; Price LH
    Ann Clin Psychiatry; 2008; 20(1):15-20. PubMed ID: 18297582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder.
    Honer WG; MacEwan GW; Gendron A; Stip E; Labelle A; Williams R; Eriksson H;
    J Clin Psychiatry; 2012 Jan; 73(1):13-20. PubMed ID: 21733490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies.
    Vieta E; Mullen J; Brecher M; Paulsson B; Jones M
    Curr Med Res Opin; 2005 Jun; 21(6):923-34. PubMed ID: 15969892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quetiapine for sleep in patients with dementia.
    Dolder CR; McKinsey J
    Consult Pharm; 2010 Oct; 25(10):676-9. PubMed ID: 21030358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
    Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
    J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA; Brecher M; Paulsson B
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder.
    Adler CM; Fleck DE; Brecher M; Strakowski SM
    J Affect Disord; 2007; 100 Suppl 1():S15-22. PubMed ID: 17383737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects.
    Datto C; Berggren L; Patel JB; Eriksson H
    Clin Ther; 2009 Mar; 31(3):492-502. PubMed ID: 19393840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study.
    Fernandez HH; Okun MS; Rodriguez RL; Malaty IA; Romrell J; Sun A; Wu SS; Pillarisetty S; Nyathappa A; Eisenschenk S
    Int J Neurosci; 2009; 119(12):2196-205. PubMed ID: 19916848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
    Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
    Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group.
    McManus DQ; Arvanitis LA; Kowalcyk BB
    J Clin Psychiatry; 1999 May; 60(5):292-8. PubMed ID: 10362435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic.
    Citrome L
    Int J Clin Pract; 2011 Feb; 65(2):189-210. PubMed ID: 21129135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guideline, education, and peer comparison to reduce prescriptions of benzodiazepines and low-dose quetiapine in prison.
    Reeves R
    J Correct Health Care; 2012 Jan; 18(1):45-52. PubMed ID: 21965158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of quetiapine off-label uses: data synthesis.
    Carney AC
    J Psychosoc Nurs Ment Health Serv; 2013 Aug; 51(8):11-8. PubMed ID: 23848159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.